Financial reports
ARS
2023 FY
Annual report to shareholders
5 Apr 24
10-K
2023 FY
Annual report
7 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
7 Apr 23
10-K
2022 FY
Annual report
8 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
Current reports
8-K
Regulation FD Disclosure
5 Mar 24
8-K
Results of Operations and Financial Condition
7 Feb 24
8-K
CVS Health Announces Leadership Appointments
5 Jan 24
8-K
CVS Health highlights path to accelerating long-term growth
5 Dec 23
8-K
Results of Operations and Financial Condition
1 Nov 23
8-K
CVS Health announces CFO Shawn Guertin to take leave of absence due to family health reasons
16 Oct 23
8-K
Regulation FD Disclosure
13 Oct 23
8-K
Departure of Directors or Certain Officers
21 Sep 23
8-K
Regulation FD Disclosure
11 Sep 23
8-K
CVS Health Launches Cordavis
23 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
2 Aug 23
424B2
Prospectus for primary offering
1 Jun 23
FWP
Free writing prospectus
30 May 23
424B3
Prospectus supplement
30 May 23
S-3ASR
Automatic shelf registration
25 May 23
S-8
Registration of securities for employees
2 May 23
S-8
Registration of securities for employees
29 Mar 23
424B2
Prospectus for primary offering
15 Feb 23
FWP
Free writing prospectus
13 Feb 23
424B3
Prospectus supplement
13 Feb 23
Proxies
PX14A6G
Letter to shareholders
16 Apr 24
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
PX14A6G
Letter to shareholders
3 May 23
PX14A6G
Letter to shareholders
26 Apr 23
DEFA14A
Additional proxy soliciting materials
7 Apr 23
DEF 14A
Definitive proxy
7 Apr 23
DFAN14A
Additional proxy materials by non-management
7 Mar 23
DFAN14A
Additional proxy materials by non-management
8 Feb 23
DFAN14A
Additional proxy materials by non-management
8 Feb 23
Other
UPLOAD
Letter from SEC
15 May 23
CORRESP
Correspondence with SEC
15 May 23
UPLOAD
Letter from SEC
11 May 23
UPLOAD
Letter from SEC
27 Aug 19
CORRESP
Correspondence with SEC
20 Aug 19
UPLOAD
Letter from SEC
8 Aug 19
CORRESP
Correspondence with SEC
10 Jul 19
CORRESP
Correspondence with SEC
28 Jun 19
UPLOAD
Letter from SEC
18 Jun 19
EFFECT
Notice of effectiveness
11 Dec 18